Cerus Corporation
US ˙ NasdaqGM ˙ US1570851014

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for William Mariner Greenman. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at William Mariner Greenman har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:CERS / Cerus Corporation President and CEO, Director 4.998.493
US:KDNY / Chinook Therapeutics Inc Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af William Mariner Greenman. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CERS / Cerus Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CERS / Cerus Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2019-06-04 CERS Greenman William Mariner 10.000 4,6000 10.000 4,6000 46.000 363 6.4900 18.900 41,09
2014-11-10 CERS Greenman William Mariner 10.000 3,9462 10.000 3,9462 39.462
2014-11-10 CERS Greenman William Mariner 2.500 3,9350 2.500 3,9350 9.838
2014-11-10 CERS Greenman William Mariner 9.300 3,9031 9.300 3,9031 36.299
2012-11-19 CERS Greenman William Mariner 3.200 3,0200 3.200 3,0200 9.664
2012-11-16 CERS Greenman William Mariner 100 2,8200 100 2,8200 282
2012-11-16 CERS Greenman William Mariner 3.000 2,8300 3.000 2,8300 8.490
2012-11-16 CERS Greenman William Mariner 3.900 2,8593 3.900 2,8593 11.151
2012-11-16 CERS Greenman William Mariner 3.000 2,8400 3.000 2,8400 8.520
2012-11-16 CERS Greenman William Mariner 3.800 2,8800 3.800 2,8800 10.944

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CERS / Cerus Corporation Insider Trades
Insidersalg CERS / Cerus Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CERS / Cerus Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-03-13 CERS Greenman William Mariner 37.748 2,8000 37.748 2,8000 105.694 220 1.2500 -58.509 -55,36
2023-03-13 CERS Greenman William Mariner 22.732 2,8000 22.732 2,8000 63.650
2022-03-14 CERS Greenman William Mariner 78.043 5,0396 78.043 5,0396 393.306
2022-03-14 CERS Greenman William Mariner 53.702 5,0395 53.702 5,0395 270.631
2022-03-14 CERS Greenman William Mariner 33.276 5,0396 33.276 5,0396 167.698
2022-02-25 CERS Greenman William Mariner 215.263 5,6879 215.263 5,6879 1.224.394
2022-02-25 CERS Greenman William Mariner 93.000 5,7274 93.000 5,7274 532.648
2019-03-13 CERS Greenman William Mariner 10.619 5,8995 10.619 5,8995 62.647
2019-03-13 CERS Greenman William Mariner 27.059 5,8997 27.059 5,8997 159.640
2019-03-12 CERS Greenman William Mariner 7.781 6,4800 7.781 6,4800 50.421
2018-03-13 CERS Greenman William Mariner 10.031 5,0500 10.031 5,0500 50.657
2018-03-12 CERS Greenman William Mariner 7.735 4,8013 7.735 4,8013 37.138
2017-03-15 CERS Greenman William Mariner 8.786 4,2101 8.786 4,2101 36.990

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CERS / Cerus Corporation Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af William Mariner Greenman som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2026-03-16 2026-03-12 4 CERS CERUS CORP
Common Stock
S - Sale X -447.757 4.998.493 -8,22 1,66 -742.023 8.283.503
2026-03-09 2026-03-06 4 CERS CERUS CORP
Common Stock
S - Sale X -78.187 5.446.250 -1,42 2,01 -156.804 10.922.454
2026-03-09 2026-03-05 4 CERS CERUS CORP
Common Stock
A - Award 193.270 5.524.437 3,63
2026-03-04 2026-03-02 4 CERS CERUS CORP
Common Stock
A - Award 1.200.000 5.331.167 29,05
2025-03-17 2025-03-14 4 CERS CERUS CORP
Common Stock
S - Sale X -122.827 4.115.845 -2,90 1,45 -178.099 5.967.975
2025-03-17 2025-03-13 4 CERS CERUS CORP
Common Stock
S - Sale X -71.086 4.238.672 -1,65 1,45 -103.075 6.146.074
2025-03-10 2025-03-07 4 CERS CERUS CORP
Common Stock
S - Sale X -60.984 4.309.758 -1,40 1,50 -91.354 6.456.017
2025-03-10 2025-03-06 4 CERS CERUS CORP
Common Stock
A - Award 165.742 4.370.742 3,94
2025-03-10 2025-03-06 4 CERS CERUS CORP
Common Stock
A - Award 975.000 4.205.000 30,19
2025-03-05 2025-03-04 4 CERS CERUS CORP
Common Stock
S - Sale X -23.023 3.230.000 -0,71 1,55 -35.651 5.001.655
2025-03-05 2025-03-03 4 CERS CERUS CORP
Common Stock
M - Exercise 57.637 3.253.023 1,80
2024-03-14 2024-03-14 4 CERS CERUS CORP
Common Stock
S - Sale X -63.611 3.181.281 -1,96 2,02 -128.195 6.411.236
2024-03-14 2024-03-13 4 CERS CERUS CORP
Common Stock
S - Sale X -62.315 3.244.892 -1,88 2,06 -128.182 6.674.743
2024-03-14 2024-03-12 4 CERS CERUS CORP
Common Stock
M - Exercise 64.666 3.307.207 1,99
2024-03-05 2024-03-01 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 575.000 3.242.541 21,56
2023-08-11 2023-08-11 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
D - Sale to Issuer -23.643 0 -100,00
2023-05-31 2023-05-30 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
S - Sale X -1.155 23.643 -4,66 23,30 -26.912 550.882
2023-05-31 2023-05-26 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 3.300 24.798 15,35
2023-03-14 2023-03-13 4 CERS CERUS CORP
Common Stock
S - Sale -22.732 2.658.346 -0,85 2,80 -63.650 7.443.369
2023-03-14 2023-03-13 4 CERS CERUS CORP
Common Stock
S - Sale -37.748 2.616.411 -1,42 2,80 -105.694 7.325.951
2023-03-14 2023-03-12 4 CERS CERUS CORP
Common Stock
M - Exercise 64.667 2.681.078 2,47
2023-03-14 2023-03-12 4 CERS CERUS CORP
Common Stock
M - Exercise 107.525 2.654.159 4,22
2023-03-03 2023-03-01 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 575.000 2.546.634 29,16
2022-03-15 2022-03-14 4 CERS CERUS CORP
Common Stock
S - Sale -33.276 1.967.192 -1,66 5,04 -167.698 9.913.861
2022-03-15 2022-03-14 4 CERS CERUS CORP
Common Stock
S - Sale -53.702 1.935.801 -2,70 5,04 -270.631 9.755.469
2022-03-15 2022-03-14 4 CERS CERUS CORP
Common Stock
S - Sale -78.043 1.885.141 -3,98 5,04 -393.306 9.500.357
2022-03-15 2022-03-12 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -64.667 129.333 -33,33
2022-03-15 2022-03-12 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -104.362 107.525 -49,25
2022-03-15 2022-03-12 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -151.666 0 -100,00
2022-03-15 2022-03-12 4 CERS CERUS CORP
Common Stock
M - Exercise 64.667 2.000.468 3,34
2022-03-15 2022-03-12 4 CERS CERUS CORP
Common Stock
M - Exercise 104.362 1.989.503 5,54
2022-03-15 2022-03-12 4 CERS CERUS CORP
Common Stock
M - Exercise 151.666 1.963.184 8,37
2022-03-01 2022-03-01 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 435.000 435.000
2022-03-01 2022-03-01 4 CERS CERUS CORP
Common Stock
A - Award 217.500 1.811.518 13,64
2022-03-01 2022-02-25 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -380.000 0 -100,00
2022-03-01 2022-02-25 4 CERS CERUS CORP
Common Stock
S - Sale -93.000 1.594.018 -5,51 5,73 -532.648 9.129.579
2022-03-01 2022-02-25 4 CERS CERUS CORP
Common Stock
S - Sale -215.263 1.687.018 -11,32 5,69 -1.224.394 9.595.590
2022-03-01 2022-02-25 4 CERS CERUS CORP
Common Stock
M - Exercise 380.000 1.902.281 24,96 3,75 1.425.000 7.133.554
2021-10-22 2021-10-21 4 KDNY CHINOOK THERAPEUTICS, INC.
Employee Stock Option (Right to Buy)
M - Exercise -1.663 0 -100,00
2021-10-22 2021-10-21 4 KDNY CHINOOK THERAPEUTICS, INC.
Common Stock
M - Exercise 1.663 21.498 8,38 2,60 4.324 55.895
2021-08-05 2021-08-03 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -100.000 0 -100,00
2021-08-05 2021-08-03 4 CERS CERUS CORP
Common Stock
M - Exercise 100.000 1.518.672 7,05 2,08 208.000 3.158.838
2021-06-07 2021-06-04 4 KDNY CHINOOK THERAPEUTICS, INC.
Stock Option (Right to Buy)
A - Award 5.948 5.948
2021-04-20 2021-04-16 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -550.000 0 -100,00
2021-04-20 2021-04-16 4 CERS CERUS CORP
Common Stock
F - Taxes -233.859 1.418.672 -14,15 6,35 -1.485.005 9.008.567
2021-04-20 2021-04-16 4 CERS CERUS CORP
Common Stock
M - Exercise 550.000 1.652.531 49,89 2,70 1.485.000 4.461.834
2021-03-16 2020-03-02 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 316.250 316.250
2021-03-16 2020-03-02 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 632.500 632.500
2021-03-16 2021-03-15 4 CERS CERUS CORP
Common Stock
S - Sale X -52.484 1.102.531 -4,54 6,38 -334.727 7.031.612
2021-03-16 2021-03-15 4 CERS CERUS CORP
Common Stock
S - Sale X -76.272 1.050.652 -6,77 6,38 -486.440 6.700.743
2021-03-16 2021-03-15 4 CERS CERUS CORP
Common Stock
S - Sale X -27.651 975.257 -2,76 6,38 -176.350 6.219.897
2021-03-16 2021-03-12 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -104.363 211.887 -33,00
2021-03-16 2021-03-12 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -151.667 151.666 -50,00
2021-03-16 2021-03-12 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -71.666 0 -100,00
2021-03-16 2021-03-12 4 CERS CERUS CORP
Common Stock
M - Exercise 104.363 1.155.015 9,93
2021-03-16 2021-03-12 4 CERS CERUS CORP
Common Stock
M - Exercise 151.667 1.126.924 15,55
2021-03-16 2021-03-12 4 CERS CERUS CORP
Common Stock
M - Exercise 71.666 1.002.908 7,70
2021-03-03 2021-03-01 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 194.000 194.000
2021-03-03 2021-03-01 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 380.000 380.000
2020-10-07 2020-10-06 4 KDNY ADURO BIOTECH, INC.
Stock Option (right to buy)
A - Award 23.522 23.522
2020-08-26 2020-08-26 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -100.000 0 -100,00
2020-08-26 2020-08-26 4 CERS CERUS CORP
Common Stock
M - Exercise 100.000 925.849 12,11 3,00 300.000 2.777.547
2020-05-28 2020-05-05 4 ADRO ADURO BIOTECH, INC.
Stock Option (Right to Buy)
A - Award 30.000 30.000
2020-03-24 2020-03-17 4 CERS CERUS CORP
Common Stock
S - Sale X -69.210 825.849 -7,73 3,59 -248.789 2.968.679
2020-03-24 2020-03-17 4 CERS CERUS CORP
Common Stock
M - Exercise 151.667 895.059 20,40
2020-03-24 2020-03-17 4 CERS CERUS CORP
Common Stock
S - Sale X -27.865 743.392 -3,61 3,59 -100.166 2.672.271
2020-03-24 2020-03-17 4 CERS CERUS CORP
Common Stock
M - Exercise 71.667 771.257 10,24
2020-03-24 2020-03-17 4 CERS CERUS CORP
Common Stock
S - Sale X -10.936 699.590 -1,54 3,59 -39.312 2.514.816
2020-03-24 2020-03-17 4 CERS CERUS CORP
Common Stock
M - Exercise 28.125 710.526 4,12
2020-03-24 2020-03-12 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -151.667 303.333 -33,33
2020-03-24 2020-03-12 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -71.667 71.666 -50,00
2020-03-24 2020-03-12 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -28.125 0 -100,00
2020-03-20 2020-03-18 4 ADRO ADURO BIOTECH, INC.
Stock Option (Right to Buy)
M - Exercise -2.458 0 -100,00
2020-03-20 2020-03-18 4 ADRO ADURO BIOTECH, INC.
Stock Option (Right to Buy)
M - Exercise -4.566 0 -100,00
2020-03-20 2020-03-18 4 ADRO ADURO BIOTECH, INC.
Stock Option (Right to Buy)
M - Exercise -12.811 0 -100,00
2020-03-20 2020-03-18 4 ADRO ADURO BIOTECH, INC.
Common Stock
M - Exercise 19.835 19.835 0,45 8.926 8.926
2019-09-24 2019-09-24 4 CERS CERUS CORP
Stock Option (Right to Buy)
M - Exercise -40.000 0 -100,00 2,15 -86.000
2019-09-24 2019-09-24 4 CERS CERUS CORP
Common Stock
M - Exercise 40.000 678.485 6,26 2,15 86.000 1.458.743
2019-06-10 2019-06-06 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 455.000 455.000
2019-06-04 2019-06-04 4 CERS CERUS CORP
Common Stock
P - Purchase 10.000 638.485 1,59 4,60 46.000 2.937.031
2019-05-15 2019-05-14 4 ADRO ADURO BIOTECH, INC.
Stock Option (Right to Buy)
A - Award 30.000 30.000
2019-04-22 2019-04-22 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -100 0 -100,00
2019-04-22 2019-04-22 4 CERS CERUS CORP
Common Stock
M - Exercise 100 628.485 0,02 1,06 106 666.194
2019-03-14 2019-03-13 4/A CERS CERUS CORP
Common Stock
S - Sale -27.059 628.385 -4,13 5,90 -159.640 3.707.283
2019-03-14 2019-03-13 4/A CERS CERUS CORP
Common Stock
S - Sale -10.619 583.777 -1,79 5,90 -62.647 3.443.992
2019-03-14 2019-03-12 4/A CERS CERUS CORP
Restricted Stock Unit
M - Exercise -71.667 143.333 -33,33
2019-03-14 2019-03-12 4/A CERS CERUS CORP
Restricted Stock Unit
M - Exercise -28.125 28.125 -50,00
2019-03-14 2019-03-12 4/A CERS CERUS CORP
Common Stock
M - Exercise 71.667 655.444 12,28
2019-03-14 2019-03-12 4/A CERS CERUS CORP
Common Stock
M - Exercise 28.125 594.396 4,97
2019-03-14 2019-03-12 4/A CERS CERUS CORP
Common Stock
S - Sale -7.781 566.271 -1,36 6,48 -50.421 3.669.436
2019-03-14 2019-03-10 4/A CERS CERUS CORP
Restricted Stock Unit
M - Exercise -22.500 0 -100,00
2019-03-14 2019-03-10 4/A CERS CERUS CORP
Common Stock
M - Exercise 22.500 574.052 4,08
2019-03-13 2019-03-13 4 CERS CERUS CORP
Common Stock
S - Sale -27.059 605.885 -4,28 5,90 -159.640 3.574.540
2019-03-13 2019-03-13 4 CERS CERUS CORP
Common Stock
S - Sale -10.619 561.277 -1,86 5,90 -62.647 3.311.254
2019-03-13 2019-03-12 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -71.667 143.333 -33,33
2019-03-13 2019-03-12 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -28.125 28.125 -50,00
2019-03-13 2019-03-12 4 CERS CERUS CORP
Common Stock
M - Exercise 71.667 632.944 12,77
2019-03-13 2019-03-12 4 CERS CERUS CORP
Common Stock
M - Exercise 28.125 571.896 5,17
2019-03-13 2019-03-12 4 CERS CERUS CORP
Common Stock
S - Sale -7.781 543.771 -1,41 6,48 -50.421 3.523.636
2019-03-13 2019-03-10 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -22.500 0 -100,00
2019-03-13 2019-03-10 4 CERS CERUS CORP
Common Stock
M - Exercise 22.500 551.552 4,25
2018-12-31 2018-12-28 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -150.000 0 -100,00
2018-12-31 2018-12-28 4 CERS CERUS CORP
Common Stock
M - Exercise 150.000 549.601 37,54 0,79 118.500 434.185
2018-10-01 2018-09-27 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -40.000 0 -100,00
2018-10-01 2018-09-27 4 CERS CERUS CORP
Common Stock
M - Exercise 40.000 399.601 11,12 4,19 167.600 1.674.328
2018-06-08 2018-06-06 4 ADRO ADURO BIOTECH, INC.
Stock Option (Right to Buy)
A - Award 20.000 20.000
2018-03-13 2018-03-13 4 CERS CERUS CORP
Common Stock
S - Sale -10.031 354.779 -2,75 5,05 -50.657 1.791.634
2018-03-13 2018-03-12 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -28.125 56.250 -33,33
2018-03-13 2018-03-12 4 CERS CERUS CORP
Common Stock
M - Exercise 28.125 364.810 8,35
2018-03-13 2018-03-12 4 CERS CERUS CORP
Common Stock
S - Sale -7.735 336.685 -2,25 4,80 -37.138 1.616.526
2018-03-13 2018-03-10 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -22.500 22.500 -50,00
2018-03-13 2018-03-10 4 CERS CERUS CORP
Common Stock
M - Exercise 22.500 344.420 6,99
2018-03-08 2018-03-01 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 215.000 215.000
2018-03-08 2018-03-01 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 430.000 430.000
2017-06-12 2017-06-08 4 ADRO ADURO BIOTECH, INC.
Stock Option (Right to Buy)
A - Award 13.000 13.000
2017-03-15 2017-03-15 4 CERS CERUS CORP
Common Stock
S - Sale -8.786 316.938 -2,70 4,21 -36.990 1.334.341
2017-03-15 2017-03-10 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -22.500 45.000 -33,33
2017-03-15 2017-03-10 4 CERS CERUS CORP
Common Stock
M - Exercise 22.500 325.724 7,42
2017-03-03 2017-03-01 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 84.375 84.375
2017-03-03 2017-03-01 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 400.000 400.000
2016-10-03 2016-09-30 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -55.000 0 -100,00
2016-10-03 2016-09-30 4 CERS CERUS CORP
Common Stock
M - Exercise 55.000 298.283 22,61 5,55 305.250 1.655.471
2016-06-10 2016-06-09 4 ADRO ADURO BIOTECH, INC.
Stock Option (Right to Buy)
A - Award 13.000 13.000
2016-03-03 2016-03-01 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 67.500 67.500
2016-03-03 2016-03-01 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 315.000 315.000
2015-12-02 2015-11-30 4 ADRO ADURO BIOTECH, INC.
Common Stock
S - Sale -3.000 0 -100,00 30,65 -91.950
2015-06-26 2015-04-14 4 ADRO ADURO BIOTECH, INC.
Stock Option (right to buy)
A - Award 40.000 40.000
2015-04-22 2015-04-20 4 ADRO ADURO BIOTECH, INC.
Common Stock
P - Purchase 3.000 3.000 17,00 51.000 51.000
2015-03-04 2015-03-02 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 500.000 500.000
2014-11-12 2014-11-10 4 CERS CERUS CORP
Common Stock
P - Purchase 9.300 184.595 5,31 3,90 36.299 720.493
2014-11-12 2014-11-10 4 CERS CERUS CORP
Common Stock
P - Purchase 2.500 175.295 1,45 3,94 9.838 689.786
2014-11-12 2014-11-10 4 CERS CERUS CORP
Common Stock
P - Purchase 10.000 172.795 6,14 3,95 39.462 681.884
2014-05-06 2014-05-05 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -46.500 0 -100,00
2014-05-06 2014-05-05 4 CERS CERUS CORP
Common Stock
M - Exercise 46.500 209.295 28,56 2,28 106.020 477.193
2014-03-28 2014-03-26 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -50 0 -100,00
2014-03-28 2014-03-26 4 CERS CERUS CORP
Common Stock
M - Exercise 50 162.795 0,03 3,52 176 573.038
2014-03-04 2014-03-03 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -53.500 46.500 -53,50
2014-03-04 2014-03-03 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 325.000 325.000
2014-03-04 2014-03-03 4 CERS CERUS CORP
Common Stock
M - Exercise 53.500 162.745 48,97 2,28 121.980 371.059
2014-03-04 2014-03-04 4/A CERS CERUS CORP
Option (Right to Buy)
M - Exercise -53.500 46.500 -53,50
2014-03-04 2014-03-04 4/A CERS CERUS CORP
Common Stock
M - Exercise 53.500 162.745 48,97 2,28 121.980 371.059
2014-03-04 2014-03-03 4/A CERS CERUS CORP
Option (Right to Buy)
A - Award 325.000 325.000
2013-08-23 2013-08-22 4 CERS CERUS CORP
Options (Right to Buy)
M - Exercise -17.250 0 -100,00
2013-08-23 2013-08-22 4 CERS CERUS CORP
Common Stock
M - Exercise 17.250 143.065 13,71 4,25 73.312 608.026
2013-03-05 2013-03-01 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 390.000 390.000
2013-01-09 2013-01-07 4 CERS CERUS CORP
Common Stock
J - Other -2.866 125.815 -2,23 2,95 -8.455 371.154
2012-11-20 2012-11-19 4 CERS CERUS CORP
Common Stock
P - Purchase 3.200 128.681 2,55 3,02 9.664 388.617
2012-11-16 2012-11-16 4 CERS CERUS CORP
Common Stock
P - Purchase 3.800 125.481 3,12 2,88 10.944 361.385
2012-11-16 2012-11-16 4 CERS CERUS CORP
Common Stock
P - Purchase 3.000 121.681 2,53 2,84 8.520 345.574
2012-11-16 2012-11-16 4 CERS CERUS CORP
Common Stock
P - Purchase 3.900 118.681 3,40 2,86 11.151 339.345
2012-11-16 2012-11-16 4 CERS CERUS CORP
Common Stock
P - Purchase 3.000 114.781 2,68 2,83 8.490 324.830
2012-11-16 2012-11-16 4 CERS CERUS CORP
Common Stock
P - Purchase 100 111.781 0,09 2,82 282 315.222
2012-03-01 2012-03-01 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 380.000 380.000
2012-03-01 2012-02-29 4 CERS CERUS CORP
Common Stock
J - Other 12.020 111.681 12,06 1,77 21.251 197.452
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)